Autologous CD84 CAR-T cell therapy

CD84-targeted CAR-T cell therapy · First Affiliated Hospital of Zhejiang University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous CD84 CAR-T cell therapy, covering 2025-01-22 to 2025-01-22. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study on the Safety and Efficacy of Autologous CD84 Chimeric Antigen Receptor T-Cell Therapy for Adult Relapsed/Refractory Acute Myeloid Leukemia. [EARLY_Phase 1]

See pricing